Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Total Current Liabilities (2023 - 2025)

Updated

Kairos Pharma (KAPA) reported Total Current Liabilities of $199,000 for Q4 2025, down 79.9% from $992,000 a year earlier.

Analysis

Kairos Pharma (KAPA) Total Current Liabilities (2023 - 2025) Analysis & Trends

Dating back to Q4 2023, Kairos Pharma's Total Current Liabilities record includes 6 quarters.

  • By year, Total Current Liabilities came in at $992,000 in FY2024 (-58.8%) and $2.41 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Kairos Pharma 10.86 Mn -1.55 Mn - 199,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 199,000.00
Jun 30, 2025 676,000.00
Mar 31, 2025 805,000.00
Dec 31, 2024 992,000.00
Sep 30, 2024 1.67 Mn
Dec 31, 2023 2.41 Mn
API Access

Kairos Pharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KAPA&period=max&api_key=YOUR_API_KEY